Cardiff Oncology, Inc. Common Stock Shares Outstanding

• Cardiff Oncology, Inc. showed an increase of +2.7% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Cardiff Oncology, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2012: 67.15 million shares | Q2 2012: 14.18 million shares | Q3 2012: 14.18 million shares | Q1 2013: 15.52 million shares | Q2 2013: 15.73 million shares | Q3 2013: 18.89 million shares | Q1 2014: 18.90 million shares | Q2 2014: 18.90 million shares | Q3 2014: 18.90 million shares | Q1 2015: 24.31 million shares | Q2 2015: 24.87 million shares | Q3 2015: 29.72 million shares | Q1 2016: 29.78 million shares | Q2 2016: 30.42 million shares | Q3 2016: 30.60 million shares | Q1 2017: 30.97 million shares | Q2 2017: 31.08 million shares | Q3 2017: 38.11 million shares | Q1 2018: 58.83 million shares | Q2 2018: 17.31 million shares | Q3 2018: 22.96 million shares | Q1 2019: 4.53 million shares | Q2 2019: 5.44 million shares | Q3 2019: 6.44 million shares | Q1 2020: 6.44 million shares | Q2 2020: 21.33 million shares | Q3 2020: 26.29 million shares | Q1 2021: 37.55 million shares | Q2 2021: 39.55 million shares | Q3 2021: 39.55 million shares | Q1 2022: 43.31 million shares | Q2 2022: 43.31 million shares | Q3 2022: 43.34 million shares | Q1 2023: 44.68 million shares | Q2 2023: 44.68 million shares | Q3 2023: 44.68 million shares | Q1 2024: 44.71 million shares | Q2 2024: 45.60 million shares | Q3 2024: 48.73 million shares | Q1 2025: 66.53 million shares | Q2 2025: 66.53 million shares | Q3 2025: 67.10 million shares.
• Over the full 15 years of available data (2011 to 2025), Cardiff Oncology, Inc.'s Common Stock Shares Outstanding has grown by 536.2%.
• Historical annual values: Fiscal year 2025: 68.31 million shares | Fiscal year 2024: 66.52 million shares | Fiscal year 2023: 44.68 million shares | Fiscal year 2022: 44.68 million shares | Fiscal year 2021: 41.96 million shares | Fiscal year 2020: 36.78 million shares | Fiscal year 2019: 8.59 million shares | Fiscal year 2018: 3.83 million shares | Fiscal year 2017: 733,217 shares | Fiscal year 2016: 30.70 million shares | Fiscal year 2015: 29.74 million shares | Fiscal year 2014: 18.92 million shares | Fiscal year 2013: 18.90 million shares | Fiscal year 2012: 15.48 million shares | Fiscal year 2011: 10.74 million shares.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026